Laboratory and Diagnostic Investigations for Suspected RHD with CHF in Children
All children with suspected rheumatic heart disease presenting with congestive heart failure should undergo immediate transthoracic echocardiography, 12-lead ECG, chest X-ray, and BNP/NT-proBNP measurement as the core diagnostic workup 1.
Essential Initial Investigations
Echocardiography (Priority #1)
Transthoracic echocardiography must be performed at or as soon as possible after initial presentation in a pediatric cardiology facility 1. This is the single most critical investigation for both diagnosing RHD and assessing heart failure severity.
The echocardiogram must include:
- Ruling out congenital heart disease (with attention to coronary arteries)
- Assessment of valvular involvement: mitral and aortic valves are most frequently affected in RHD 2
- Quantification of mitral and aortic regurgitation - pathologic regurgitation is the hallmark of RHD
- Left ventricular systolic function: shortening fraction (SF) and/or ejection fraction (EF)
- LV end-diastolic dimension Z-score measurement
- RV function assessment (qualitative or quantitative) and RV pressure
- LV diastolic function evaluation
Important caveat: Standard portable echocardiography interpreted by experienced cardiologists is essential for definitive diagnosis 3. While handheld echocardiography has 97.8% sensitivity for detecting definite RHD 3, comprehensive echocardiography by pediatric cardiology is necessary for accurate valvular disease assessment 4, 5.
Electrocardiogram
A 12-lead ECG must be performed at presentation to exclude arrhythmias, conduction abnormalities, and assess for chamber enlargement 1. In RHD with CHF, look specifically for:
- Biatrial enlargement (common in valvular disease)
- Ventricular hypertrophy patterns
- Arrhythmias (particularly atrial fibrillation in advanced disease)
- PR interval prolongation (first-degree AV block can occur in acute rheumatic fever)
Biomarkers
BNP or NT-proBNP levels should be measured as they are useful in distinguishing heart failure from respiratory or other noncardiac disease 1. These biomarkers:
- Confirm the diagnosis of HF in the acute setting (Strong Recommendation, Moderate-Quality Evidence)
- Correlate with disease severity
- NT-proBNP may be advantageous in children due to longer half-life (70 vs 15 minutes) and greater stability
Chest X-ray
Obtain chest radiography to assess:
- Cardiomegaly (cardiac silhouette enlargement)
- Pulmonary congestion or edema
- Pleural effusions
Additional Laboratory Tests
Inflammatory Markers
For suspected acute rheumatic fever with carditis:
- Erythrocyte sedimentation rate (ESR)
- C-reactive protein (CRP)
- Anti-streptolysin O (ASO) titer or anti-DNase B
- Throat culture for Group A Streptococcus
Baseline Metabolic Assessment
Monitor these parameters as they guide diuretic therapy and assess end-organ dysfunction:
- Electrolytes (sodium, potassium, chloride)
- Renal function (creatinine, BUN)
- Liver function tests (may be elevated with hepatic congestion)
- Complete blood count (exclude severe anemia as contributing factor)
Follow-up Echocardiography
Periodic follow-up echocardiography is mandatory to reassess ventricular function, monitor response to medical therapy, and detect progression of valvular dysfunction 1. Repeat immediately if significant clinical deterioration or improvement occurs.
Common Pitfalls to Avoid
Do not rely on auscultation alone: Cardiac auscultation has uniformly poor sensitivity (only 22.2% for definite RHD and 16.4% for borderline/definite RHD) 3. Many children with significant RHD have minimal or no audible murmurs.
Do not delay echocardiography: 87% of new-onset heart failure cases only reach diagnosis when severely decompensated 1. Early echocardiographic diagnosis is critical for mortality reduction.
Recognize that RHD can remain asymptomatic: Subclinical carditis exists in approximately 35.7% of patients without clinical cardiac manifestations 2, emphasizing the importance of echocardiography over clinical examination alone.
Consider multivalvular involvement: In severe rheumatic carditis, regurgitation of at least two valves with biventricular dysfunction carries 50% risk of intractable heart failure and 24% mortality 6.
Clinical Context
In endemic regions globally, RHD remains a predominant cause of pediatric heart failure 1, 7. The diagnostic approach must be aggressive and comprehensive, as less than 50% of children presenting with symptomatic heart failure from RHD survive 5 years without cardiac transplantation 1. Early echocardiographic diagnosis enables initiation of secondary prophylaxis with benzathine penicillin, which prevents recurrent rheumatic fever and progressive valvular damage 8, 9.